Sign Up Today and Learn More About H1 Stock
Invest in or calculate the value of your shares in H1 or other pre-IPO companies through EquityZen's platform.
H1 Stock (HON)
H1 provides the largest global healthcare platform to help life sciences companies, hospitals, academic medical centers, and health systems.
About H1 Stock
Founded
2017
Headquarters
New York, NY, US
Industries
Messaging and Telecommunications, Content and Publishing, Sports
H1 provides the largest global healthcare platform to help life sciences companies, hospitals, academic medical centers, and health systems connect with providers, find clinical research, locate industry experts, and benchmark their organization. As the trusted source of information on healthcare professionals and institutions, H1 connects the entire healthcare ecosystem through real-time data and clinical findings. It was founded in 2017 and is based in New York, New York.
H1 Press Mentions
Stay in the know about the latest news on H1
H1 acquires Ribbon Health to expand its reach to health plan, digital health markets
fiercehealthcare • Jan 10, 2025
H1 Launches New Solution Empowering Doctors to Find Global Health Opportunities
globenewswire • Jun 25, 2024
H1 Launches New Solution Empowering Doctors to Find Global Health Opportunities
globenewswire • May 24, 2024
H1 Recognized as One of Forbes' Best Startup Employers in
globenewswire • Apr 05, 2024
H1 Honored With Spot On the New York Digital Health 100 For Third Straight Year
globenewswire • Apr 05, 2024
H1 Management
Leadership team at H1
CEO and Co-Founder
Ariel Katz
Co-Founder
Ian Sax
Join now and verify your accreditation status to gain access to:
- H1 Current Valuation
- H1 Stock Price
- H1 Management
- Available deals in H1 and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- H1 Cap Table and Funding History by Share Class and Liquidity Preferences
- H1 Revenue and Financials
- H1 Highlights
- H1 Business Model
- H1 Risk Factors
- H1 Research Report from SACRA Research
Trading H1 Stock
How to invest in H1 stock?
Accredited investors can buy pre-IPO stock in companies like H1 through EquityZen funds. These investments are made available by existing H1 shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell H1 stock?
Shareholders can sell their H1 stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
